The USPTO recently announced its Relevant Prior Art (RPA) Initiative, seeking to leverage electronic resources to improve an examiner’s access to relevant information from applicant’s other related applications. These resources may include related U.S. applications, international applications under the PCT, and counterpart foreign applications by the same applicant. What are the advantages? Simplifies application process for applicant Speeds up examination process Increases efficiency of prosecution procedures Improves prosecution quality What you should be aware of Notification of application included in RPA initiative. You will receive a Notice of Imported Citations informing you of your application’s inclusion in the Initiative andContinue reading
Although CRISPR was known to have an important role in bacterial immunity for over a decade, it is only in the last 5 years that it has garnered interest as a gene editing tool. Increasing investment in this field is indicative of global market opportunities for CRISPR-Cas9 over existing alternatives. The objective of this study is to explore the market and patenting activity in CRISPR-Cas9 gene editing technology. This study considers issued patents and pending published applications related to CRISPR-Cas9 published since January 1, 2007. Search strategies using various combinations of keywords, classification codes, and prominent assignees resulted in moreContinue reading
MaxVal has recapped all the latest US patent trends from the first half of 2016.
The total number of patents issued by the USPTO between Jan’16 to June ‘16 is 168,077.